» Authors » Yong W Cho

Yong W Cho

Explore the profile of Yong W Cho including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 452
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Kuo H, Poommipanit N, Sampaio M, Reddy P, Cho Y, Bunnapradist S
Transplantation . 2010 Feb; 89(4):434-9. PMID: 20177345
Background: The objective of this study was to identify the risk factors for new-onset diabetes mellitus (NODM) after kidney transplant in pediatric renal transplant recipients using Organ Procurement Transplant Network/United...
12.
Fong T, Hou L, Hutchinson I, Cicciarelli J, Cho Y
Transplantation . 2009 Nov; 88(9):1137-41. PMID: 19898211
Background: Prevalence of hepatitis C infection (HCV) among heart transplant (OHT) recipients ranges from 7% to 18%. Despite the paucity of data regarding the outcomes of heart transplant recipients who...
13.
Shah T, Bunnapradist S, Hutchinson I, Pravica V, Cho Y, Mendez R, et al.
Clin Transplant . 2008 Aug; 22(6):794-802. PMID: 18713264
The maximum age of recipients expected to benefit with a kidney transplant has increased in the past three decades. In 1980, patients older than age 50 were not listed for...
14.
Chavalitdhamrong D, Gill J, Takemoto S, Madhira B, Cho Y, Shah T, et al.
Transplantation . 2008 Jun; 85(11):1573-9. PMID: 18551062
Background: The organ shortage has resulted in more use of older deceased donor kidneys. Data are limited on the impact of donor aged 70 years and older on transplant outcomes....
15.
Gill J, Cho Y, Danovitch G, Wilkinson A, Lipshutz G, Pham P, et al.
Transplantation . 2008 Jan; 85(1):62-8. PMID: 18192913
Background: The organ shortage has resulted in increased use of kidneys from expanded criteria donors (ECD). For ECD kidneys unsuitable for single use, dual kidney transplants (DKT) may be possible....
16.
Bajwa M, Cho Y, Pham P, Shah T, Danovitch G, Wilkinson A, et al.
Transplantation . 2007 Dec; 84(11):1399-405. PMID: 18091515
Background: Although the degree of glomerulosclerosis on pretransplant donor biopsy is one criterion used in the decision to accept a deceased donor kidney, its relationship with graft survival remains controversial....
17.
Huang E, Cho Y, Hayashi R, Bunnapradist S
Transplantation . 2007 Nov; 84(7):821-8. PMID: 17984833
Background: The use of alemtuzumab for induction therapy in kidney transplantation has been increasing. Herein is a report of graft outcomes associated with alemtuzumab induction from the Organ Procurement and...
18.
Huang E, Cho Y, Shah T, Peng A, Hayashi R, Bunnapradist S
Clin Transpl . 2007 Apr; :343-54. PMID: 17424750
The use of alemtuzumab for induction therapy is increasing. 7.6% of antibody induction recipients in 2003 and 9.3% of induction recipients in 2004 received alemtuzumab. Antibody induction, especially T-cell depleting...
19.
Shah T, Kasravi A, Huang E, Hayashi R, Young B, Cho Y, et al.
Transplantation . 2007 Jan; 82(12):1673-6. PMID: 17198258
Background: New-onset diabetes mellitus after kidney transplantation (NODM) is an important co morbid condition that is associated with inferior graft and patient survival. The objective of this study was to...
20.
Simpson N, Cho Y, Cicciarelli J, Selby R, Fong T
Transplantation . 2006 Nov; 82(10):1298-303. PMID: 17130778
Background: There may be an allograft-enhancing effect by the liver on the renal allograft in the setting of simultaneous combined liver-kidney transplantation (CLKT) from the same donor. This study was...